Evidence map›Paper›PMID 36167600›Full record

ReviewZeitschrift fur medizinische Physik2023

EANM guidelines for PET-CT and PET-MR routine quality control.

Michel Koole, Ian Armstrong, Aron K Krizsan, Anne Stromvall, Dimitris Visvikis, Bernhard Sattler, Stephan G Nekolla, John Dickson, EANM Physics committee

Abstract readReview
In one paragraph

Review in Zeitschrift fur medizinische Physik, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Mapping the knowledge landscape of the PET/MR domain: a multidimensional bibliometric analysis.European journal of nuclear medicine and molecular imaging · 2025
    Review
  5. Improved Accuracy and Reliability of PRIMARY Scoring Using Delayed [Molecular imaging and radionuclide therapy · 2025
    Article
  6. The Use of [Pharmaceuticals (Basel, Switzerland) · 2025
    Review
  7. Prediction of clinically significant prostate cancer by [European journal of nuclear medicine and molecular imaging · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Michel KooleNuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Belgium. Electronic address: michel.koole@kuleuven.be.
Ian ArmstrongNuclear Medicine, Manchester University NHS Foundation Trust, Manchester, United Kingdom.
Aron K KrizsanScanoMed Nuclear Medicine Centers, Debrecen, Hungary.
Anne StromvallRadiation Physics, Department of Radiation Sciences, Umeå universitet, Umeå, Sweden.
Dimitris VisvikisLaTIM, INSERM, UMR 1101, Univ Brest, Brest, France.
Bernhard SattlerDepartment of Nuclear Medicine, University Medical Centre Leipzig, Leipzig, Germany.
Stephan G NekollaNuklearmedizinische Klinik und Poliklinik, Klinikum rechts der Isar der Technischen Universität München, München, Germany.
John DicksonInstitute of Nuclear Medicine, University College London Hospital, London, United Kingdom.
EANM Physics committee

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present guidelines by the European Association of Nuclear Medicine (EANM) for routine quality control (QC) of PET-CT and PET-MR systems. These guidelines are partially based on the current EANM guidelines for routine quality control of Nuclear Medicine instrumentation but focus more on the inherent multimodal aspect of the current, state-of-the-art PET-CT and PET-MR scanners. We briefly discuss the regulatory context put forward by the International Electrotechnical Commission (IEC) and European Commission (EC) and consider relevant guidelines and recommendations by other societies and professional organizations. As such, a comprehensive overview of recommended quality control procedures is provided to ensure the optimal operational status of a PET system, integrated with either a CT or MR system. In doing so, we also discuss the rationale of the different tests, advice on the frequency of each test and present the relevant MR and CT tests for an integrated system. In addition, we recommend a scheme of preventive actions to avoid QC tests from drifting out of the predefined range of acceptable performance values such that an optimal performance of the PET system is maintained for routine clinical use.

Indexed as

Nuclear MedicinePositron Emission Tomography Computed TomographyPhantoms, ImagingPositron-Emission TomographyQuality ControlGuidelinesPET-CTPET-MRQuality control

Identifiers

PMID36167600
PMCPMC10068535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.